A novel model to assess disease severity and prevention strategies in rheumatic heart disease

Gorton, D., Chilton, L., Day, J., Govan, B., Bryant, S., Tacke, S., and Ketheesan, N. (2010) A novel model to assess disease severity and prevention strategies in rheumatic heart disease. In: Fulbright Symposium. p. 74. From: 2010 Fulbright 60th Anniversary Symposium, 18-20 August 2010, Cairns, Australia.

[img]
Preview
PDF (Abstract Only) - Published Version
Download (181kB)
 
31


Abstract

Background: Rheumatic fever (RF) can follow group A streptococcal infection (GAS) and may affect heart valves (rheumatic heart disease, RHO). In the absence of appropriate treatment, repeated occurrences of RF may lead to heart failure. RF/RHD remain the major cause of cardiovascular morbidity and mortality among children and young adults in many underdeveloped, tropical regions. This includes some communities in Australia's north which have unacceptably high rates of RF/RHD. We are using a novel rat autoimmune valvulitis model to determine heart disease severity following repetitive group A streptococcal infection and to assess prevention strategies.

Methods: Rats were immunised and boosted 1-3 times with group A streptococcal M protein. A proportion of rats were given daily doses of anti-fibrotic drug Enalapril at 10mg/kg. Disease severity was assessed histologically and electrophysiological changes analysed by ECG and echocardiography. Antibody and T cell immune responses were measured by ELISA and proliferation assays respectively.

Results: Rats boosted 2-3 times with GAS M protein had higher immune responses and more severe heart damage than those boosted once only. There was a trend towards longer PR interval and decreased fractional shortening in M protein-immunised rats compared to control rats.

Conclusions: This model demonstrates many of the immune and functional responses characteristic of RF/RHD and provides a valuable tool for better understanding disease progression and evaluating treatment or vaccination strategies.

Item ID: 27379
Item Type: Conference Item (Abstract / Summary)
ISBN: 978-0-9808183-4-5
Related URLs:
Date Deposited: 03 Jun 2013 04:59
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1107 Immunology > 110703 Autoimmunity @ 45%
11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110309 Infectious Diseases @ 45%
11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111701 Aboriginal and Torres Strait Islander Health @ 10%
SEO Codes: 92 HEALTH > 9203 Indigenous Health > 920399 Indigenous Health not elsewhere classified @ 30%
92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 40%
92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920412 Preventive Medicine @ 30%
Downloads: Total: 31
Last 12 Months: 1
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page